Checkpoint inhibitor antibody type influences the development of cutaneous immune-related adverse events: A multi-institutional study

Affiliations

• ¹ Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
• ² Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
• ³ Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.
• ⁴ Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.
• ⁵ Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Harvard Medical School, Boston, Massachusetts. Electronic address: ysemenov@mgh.harvard.edu.